Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT)

Part of paid clinical trials in Los Angeles, California.

Sponsor
M.D. Anderson Cancer Center
Study ID
NCT03460769
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
30 Years - 84 Years
Healthy Volunteers
Not accepted

Interventions

  • Data Management and Monitoring — OTHER
    The Coordinating and Data Management Center (CDMC) at MD Anderson Cancer responsible for the coordination and data management for the Evaluation of a mixed meal test for Diagnosis and characterization of Type 3c diabetes mellitus secondary to pancreatic cancer and chronic pancreatitis (DETECT), which is part of the NIH U01 funded Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC).

Study Details

The Coordinating and Data Management Center (CDMC) at MD Anderson Cancer will be responsible for the coordination and data management for the Evaluation of a mixed meal test for Diagnosis and characterization of Type 3c diabetes mellitus secondary to pancreatic cancer and chronic pancreatitis (DETECT), which is part of the NIH U01 funded Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC). Similar to all studies that will be coordinated and managed by the CDMC, no patient enrollment will occur at MDACC. All patient recruitment will occur at external sites that are a part of the CPDPC, which are listed in the appended DETECT protocol. The data management systems, auditing, and monitoring effort are supported by the CDMC.

Key Dates

Start date
Apr 1, 2021
Status verified
May 2026
Primary completion
Jun 30, 2027
Completion
Jun 30, 2027

Study Design

Enrollment
775 participants (estimated)

Arms

  • Arm: Pancreatic Cancer
    The Coordinating and Data Management Center (CDMC) at MD Anderson Cancer will be responsible for the coordination and data management for the Evaluation of a mixed meal test for Diagnosis and characterization of Type 3c diabetes mellitus secondary to pancreatic cancer and chronic pancreatitis (DETECT).
  • Arm: Chronic Pancreatitis
    The Coordinating and Data Management Center (CDMC) at MD Anderson Cancer will be responsible for the coordination and data management for the Evaluation of a mixed meal test for Diagnosis and characterization of Type 3c diabetes mellitus secondary to pancreatic cancer and chronic pancreatitis (DETECT).
  • Arm: Type 3c Diabetes Mellitus
    The Coordinating and Data Management Center (CDMC) at MD Anderson Cancer will be responsible for the coordination and data management for the Evaluation of a mixed meal test for Diagnosis and characterization of Type 3c diabetes mellitus secondary to pancreatic cancer and chronic pancreatitis (DETECT).

Primary Outcome Measure

Protocol and Regulatory Compliance Monitoring of Regulatory Documents for Consortium Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC) [ Time Frame: 3 years ]

Central Contacts

Locations (10)

FacilityCityStateZIPSite coordinators
Cedars-Sinai Medical CenterLos AngelesCalifornia90048-
Stanford UniversityStanfordCalifornia94305-
University of FloridaGainesvilleFlorida32610-
Indiana UniversityCarmelIndiana46280-
University of MinnesotaMinneapolisMinnesota55454-
Mayo ClinicRochesterMinnesota55905-
Ohio State UniversityColumbusOhio43210-
University of Pittsburgh Medical CenterPittsburghPennsylvania15213-
Baylor College of MedicineHoustonTexas77030-
University of Texas MD Anderson Cancer CenterHoustonTexas77030
Suresh Chari, MBBS
[email protected]
713-501-3714
Ying Yuan, PHD
[email protected]
(713) 563-4271

Find similar trials in Los Angeles, CA

By condition
Pancreatic cancer
By specialty
OncologyGI oncology
By research site
Cedars-Sinai Medical Center· Los Angeles, CAStanford University· Stanford, CAUniversity of Florida· Gainesville, FLIndiana University· Carmel, INUniversity of Minnesota· Minneapolis, MNMayo Clinic· Rochester, MN

Related Studies